IJGC Podcast

The International Journal of Gynecological Cancer (IJGC) podcast explores the latest research on detection, prevention, diagnosis, and treatment of gynecologic malignancies. Enjoy interviews with leading experts as they discuss novel and relevant topics in the field of gynecologic cancer. Join Editor-in-Chief Dr. Pedro Ramirez and his guests for an interactive and educational experience. Subscribe now or listen on your favourite podcast platform. IJGC - ijgc.bmj.com - is the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.

Listen on:

  • Apple Podcasts
  • Podbean App
  • Spotify
  • Amazon Music
  • TuneIn + Alexa
  • iHeartRadio
  • PlayerFM
  • Listen Notes
  • Podchaser
  • BoomPlay

Episodes

Thursday Oct 14, 2021

In this episode of the IJGC Podcast, Editorial Fellow Sara Nasser discusses the contents of the October issue of IJGC in Arabic.

Wednesday Oct 06, 2021

In this episode of the IJGC Podcast, Editorial Fellows Cecilia Darin and Erick Estrada discuss the contents of the October issue of IJGC in Spanish.

Wednesday Sep 29, 2021

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Kathleen Schmeler to discuss the ConCerv Trial. Dr. Schmeler is the lead author of ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer, which is the Lead Article of IJGC’s October 2021 issue. Dr. Schmeler is a Professor in Gynecologic Oncology at The University of Texas MD Anderson Cancer Center. She provides care to women with gynecologic malignancies including surgery, chemotherapy and preventive services. Dr. Schmeler is also the Executive Director of Global Oncology for the MD Anderson Cancer Network. Her research interest is in cervical cancer prevention and treatment, particularly for resource-constrained countries and medically underserved communities in the US.
( https://ijgc.bmj.com/content/early/2021/09/06/ijgc-2021-002921.share )
@kmschmeler @MDAndersonNews
Highlights:
•The ConCerv trial is the first prospective study of conservative surgery in women with low-risk cervical cancer. It included 14 sites in 9 countries.
•Findings from the ConCerv Trial offer prospective data supporting a more conservative approach to low-risk patients, sparing them the early and late morbidity associated with radical procedures.
•It will also allow for safer cervical cancer surgery in low- and middle-income countries, where the burden of cervical cancer is highest.
•In the our study, conservative surgery was associated with a 3.5% recurrence rate in women with low-risk cervical cancer. In addition, the rate of positive lymph nodes was 5%, with lymph node assessment recommended in this low-risk population.
•Further study is needed to determine long term outcomes and optimal pathologic criteria for conservative surgery."

Wednesday Sep 29, 2021

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Professor Christina Fotopoulou for another installment of the Mentor’s Podcast. Professor Fotopoulou works at the Department of Surgery and Cancer at Imperial College London, UK. She is an elected ESGO council member and Chair of the ESGO guidelines committee.
Christina Fotopoulou (@CF_PC_OvCaGroup / @HopkinsMedNews)
Highlights:
- Early support from mentors and "giants" in the field, national and international networking and early focusing/specialization in the field of interest are keys to success
- Try to turn your weaknesses and failures to learning points and opportunities to make you stronger
- Hard work, kindness and caring for patients, team spirit, professionalism and dedication are the main keys of success next to any talent and luck that anyone might be fortunate enough to have

Friday Sep 24, 2021

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Yuefeng Wang and Matthew Ballo to discuss role of hysterectomy in stage IVB uterine cancer. Dr. Yuefeng Wang is a radiation oncologist and Dr. Matthew Ballo is a radiation oncologist, and the Chair of the Department of Radiation Oncology, West Cancer Center and Research Institute, Memphis, TN.
Yuefeng Wang and Matthew Ballo (@YuefengWang2 / @west_cancer)
Highlights:
-For uterine cancer with pelvic/abdomen metastasis, there is survival benefit associated with total abdominal hysterectomy, in addition to systemic therapy. However, we do not know if there is any role of total abdominal hysterectomy for patient with distant organ metastasis.
-In this retrospective, hypothesis-generating study including 3,200 uterine cancer patients with distant organ metastasis, total abdominal hysterectomy plus chemotherapy was associated with significant longer survival (19.8 vs 11.0 months, p

Friday Sep 17, 2021

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Kemi Doll to discuss racial disparities in endometrial cancer screening with ultrasound. Dr. Kemi Doll is a gynecologic oncologist, health services researcher, and Associate Professor at the University of Washington, Department of Obstetrics and Gynecology. Her expertise is in Black-White disparities in endometrial cancer outcomes in the United States.
Kemi Doll (@kemidoll / @uwmedicine / @uwashobgyn)

ENDO3 Trial with Andreas Obermair

Wednesday Sep 08, 2021

Wednesday Sep 08, 2021

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Andreas Obermair to discuss the ENDO3 Trial. Dr. Obermair is a gynaecological oncologist in Brisbane, Australia, promoting surgery with proven better patient outcomes.
Highlights
•ENDO3 exemplifies the need to question current standard clinical practice if this practice – while performed routinely - has not shown patient benefit.
•ENDO3 employs meticulous methodology and has been designed with input from gynaecological oncologists, medical and radiation oncologists, behavioural scientists, exercise physiologists, statisticians, translational scientists, including the patient perspective.
•ENDO3 will offer unique insights into clinically meaningful outcomes that will shape our approach to surgical treatment of endometrial cancer in the future.
Andreas Obermair (@AndreasObermair / @UQ_gynae_cancer)

Tuesday Sep 07, 2021

In this episode of the IJGC Podcast, Editorial Fellow Sara Nasser discusses the contents of the September issue of IJGC in Arabic.

Tuesday Sep 07, 2021

In this episode of the IJGC Podcast, Editorial Fellow Irina Tsibulak discusses the contents of the September issue of IJGC in Russian.

Friday Sep 03, 2021

In this episode of the IJGC Podcast, Editorial Fellows Cecilia Darin and Erick Estrada discuss the contents of the September issue of IJGC in Spanish.

* The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Copyright 2023 All rights reserved.

Version: 20241125